Deregulated Expression of the Per1 and Per2 in Human Gliomas

Growing evidence shows that the deregulation of the circadian clock plays an important role in the development of malignant tumors, including gliomas. However, the molecular mechanisms of genes controlling circadian rhythm in glioma cells have not been explored. Using reverse transcription polymeras...

Full description

Saved in:
Bibliographic Details
Published in:Canadian journal of neurological sciences 2010-05, Vol.37 (3), p.365-370
Main Authors: Xia, He-chun, Niu, Zhan-feng, Ma, Hui, Cao, Shuan-zhu, Hao, Shao-cai, Liu, Zhong-tao, Wang, Fan
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Brain Neoplasms - genetics
Brain Neoplasms - physiopathology
Child
Female
Gene Expression Regulation, Neoplastic - physiology
Glioma - genetics
Glioma - physiopathology
Humans
Male
Middle Aged
Original Article
Period Circadian Proteins - genetics
Period Circadian Proteins - metabolism
Retrospective Studies
RNA, Messenger - metabolism
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Growing evidence shows that the deregulation of the circadian clock plays an important role in the development of malignant tumors, including gliomas. However, the molecular mechanisms of genes controlling circadian rhythm in glioma cells have not been explored. Using reverse transcription polymerase chain reaction and immunohistochemistry techniques, we examined the expression of two important clock genes, Per1 and Per2, in 33 gliomas. In this study, out of 33 gliomas, 28 were Per1-positive, and 23 were Per2-positive. The expression levels of Per1 and Per2 in glioma cells were significantly different from the surrounding non-glioma cells (P0.05). While there was no difference in the intensity of immunoactivity for Per2 between high-grade gliomas and low-grade gliomas (r=-0.330, P=0.061), the expression level of Per1 in high-grade gliomas was significantly lower than that in low-grade gliomas(r=-0.433, P=0.012). In this study, we found that the expression of Per1 and Per2 in glioma cells was much lower than in the surrounding non-glioma cells. Therefore, we suggest that disturbances in Per1 and Per2 expression may result in the disruption of the control of normal circadian rhythm, thus benefiting the survival of glioma cells. Differential expression of circadian clock genes in glioma and non-glioma cells may provide a molecular basis for the chemotherapy of gliomas.
ISSN:0317-1671
2057-0155
DOI:10.1017/S031716710001026X